Last reviewed · How we verify
whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose
whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose is a Biologic drug developed by Sinovac Biotech Co., Ltd. It is currently FDA-approved.
At a glance
| Generic name | whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose |
|---|---|
| Sponsor | Sinovac Biotech Co., Ltd |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose CI brief — competitive landscape report
- whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose updates RSS · CI watch RSS
- Sinovac Biotech Co., Ltd portfolio CI
Frequently asked questions about whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose
What is whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose?
whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose is a Biologic drug developed by Sinovac Biotech Co., Ltd.
Who makes whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose?
whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose is developed and marketed by Sinovac Biotech Co., Ltd (see full Sinovac Biotech Co., Ltd pipeline at /company/sinovac-biotech-co-ltd).
What development phase is whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose in?
whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose is FDA-approved (marketed).